Commercial Information Circulars

24-hour hotline : 23 922 922

e-mail address : enquiry@tid.gov.hk

Ref. : EIC 631/2/5/1

26 January 2024

Dear Sirs,

Commercial Information Circular No. 106/2024

The Mainland of China : Public Consultation on "Notice Concerning Issues Related to Optimising the Application for Marketing and Registration of Overseas-produced Drugs Already Marketed Domestically to be Shifted to Domestic Production (Consultation Draft)"

The National Medical Products Administration is seeking comments from the public on the "Notice Concerning Issues Related to Optimising the Application for Marketing and Registration of Overseas-produced Drugs Already Marketed Domestically to be Shifted to Domestic Production (Consultation Draft)". The deadline is 23 February 2024. Please refer to the Appendix (pdf format) for the notice (available in Chinese only).

ENQUIRIES

2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.

Yours faithfully,

(Miss Sindy LEE)
for Director-General of Trade and Industry

Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.